MedPath

Serine

Generic Name
Serine
Brand Names
Hepatamine 8, Clinimix 2.75/5, Clinimix E 2.75/5, Clinisol 15, Premasol, Procalamine 3, Plenamine, Primene, Periolimel, Freamine III 10, Trophamine 10 %, Aminosyn II 7 %, Aminosyn-PF 7%, Prosol, Sulfite-free, Travasol 10, Olimel, Freamine 6.9
Drug Type
Small Molecule
Chemical Formula
C3H7NO3
CAS Number
56-45-1
Unique Ingredient Identifier
452VLY9402
Background

A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids.

Indication

Used as a natural moisturizing agent in some cosmetics and skin care products.

Associated Conditions
Iron Deficiency Anemia (IDA), Iron Deficiency (ID)
Associated Therapies
Amino acid supplementation

Phosphopeptide Enrichment and LC-MS/MS Analysis to Study the Phosphoproteome of ...

Phosphoproteomic analysis of CHO cells using MOAC and IMAC for phosphopeptide enrichment, followed by site-specific identification via LC-MS, MSA, and MS3, applicable to quantitative phosphoproteomic studies.
neurologylive.com
·

Radiprodil Significantly Reduces Seizure Frequency in Phase 1b Honeycomb Study of GRIN-Related Neurodevelopmental Disorder Patients

Phase 1 Honeycomb study data showed radiprodil (GRIN Therapeutics) was well-tolerated and significantly reduced seizure frequency in GRIN-related neurodevelopmental disorder patients, supporting further development. 15 patients with gain-of-function variants in GRIN1, GRIN2A, GRIN2B, or GRIN2D were analyzed, with a median 86% reduction in seizure frequency. 71% of patients experienced at least a 50% reduction in countable motor seizures, and 1 patient was seizure-free. Clinician and caregiver assessments indicated clinical improvement. The study aims to progress to Phase 3 development.
© Copyright 2025. All Rights Reserved by MedPath